Fecal Microbiota Transfer for Diabetes Control After Bariatric Surgery

We are studying whether fecal microbiota transfer can help improve blood sugar levels in patients who had bariatric surgery and are in diabetes remission. This trial will explore its effects on insulin production and overall health.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Double Encapsulated Oral Transplant of Fecal Microbiota
Allogeneic Faecal Microbiota

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Assistance Publique Hopitaux De Paris
Endocrinologie et metabolisme
Salpêtrière, France
Fondation Cardiometabolisme Et De Nutrition
Département de Cardiometabolisme Et De Nutrition de l'ICAN
Salpêtrière, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.